AorTech International Plc (AOR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AorTech International Plc (AOR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3290
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AorTech International plc (AorTech) is an Intellectual Property (IP) holding company. It develops and commercializes biologically stable polymers for next generation medical devices. It provides a broad range of polyurethane technologies for applications in cardiovascular surgery, interventional cardiology, cardiac rhythm management, orthopedic, plastic surgery, gastroenterological and urological applications. It offers Elast-Eon biostable polyurethanes used in medical devices for long term implantation; ECSil, biomedical polymers for pacing and neurostimulation leads, spinal disc, and breast implant; and Elast-Eon reaction injection molding (RIM) products. The company manufactures and distributes Elast-Eon materials through Biomerics LLC. AorTech is headquartered in Surrey, Scotland, the UK.

AorTech International Plc (AOR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AorTech International Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AorTech International Plc, Medical Devices Deals, 2012 to YTD 2018 8
AorTech International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AorTech International Plc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
AorTech International Raises USD0.7 Million in Private Placement of Shares 10
AorTech International to Raise USD2.3 Million in Private Placement of Shares 12
AorTech International to Raise USD0.5 Million in Rights Offering of Shares 13
AorTech International Plc – Key Competitors 14
AorTech International Plc – Key Employees 15
AorTech International Plc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Jul 20, 2018: AorTech International: Final results for the year ended 31 March 2018 17
Dec 11, 2017: AorTech International:Unaudited Interim Results For the six months ended 30 September 2017 21
Aug 16, 2017: AorTech International: Audited results for the year ended 31 March 2017 24
Legal and Regulatory 26
Nov 20, 2017: AorTech International: Settlement of Litigation 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
AorTech International Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AorTech International Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AorTech International Plc, Medical Devices Deals, 2012 to YTD 2018 8
AorTech International Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AorTech International Raises USD0.7 Million in Private Placement of Shares 10
AorTech International to Raise USD2.3 Million in Private Placement of Shares 12
AorTech International to Raise USD0.5 Million in Rights Offering of Shares 13
AorTech International Plc, Key Competitors 14
AorTech International Plc, Key Employees 15
AorTech International Plc, Subsidiaries 16

List of Figures
AorTech International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AorTech International Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AorTech International Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AorTech International Plc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[AorTech International Plc (AOR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genfit SA (GNFT):医療機器:M&Aディール及び事業提携情報
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program …
  • MTBC Inc (MTBC):企業の財務・戦略的SWOT分析
    Summary MTBC Inc (MTBC) is a healthcare IT company that offers web-based solutions and related business services. The company offers products such as electronic health records, patient engagement, practice management, and mhealth. Its services include medical billing, medical transcription, consulta …
  • Qisda Corporation
    Qisda Corporation - Strategy, SWOT and Corporate Finance Report Summary Qisda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Provectus Biopharmaceuticals Inc (PVCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Itausa – Investimentos Itau S.A.:企業の戦略・SWOT・財務情報
    Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report Summary Itausa - Investimentos Itau S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Dialog Group Bhd (DIALOG):企業の財務・戦略的SWOT分析
    Dialog Group Bhd (DIALOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • 3i Group Plc:企業のM&A・事業提携・投資動向
    3i Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's 3i Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Jyske Bank A/S:企業の戦略・SWOT・財務情報
    Jyske Bank A/S - Strategy, SWOT and Corporate Finance Report Summary Jyske Bank A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Leadiant Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Leadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matu …
  • Sinovel Wind Group Co Ltd (601558):企業の財務・戦略的SWOT分析
    Summary Sinovel Wind Group Co Ltd (Sinovel) is a wind turbine manufacturing company. The company designs, manufactures, develops, and commercializes the large-scale of onshore, offshore and intertidal wind turbines. Its products include SL1500 series wind turbines, SL2000 series wind turbines, SL300 …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Analytik Jena AG:医療機器:M&Aディール及び事業提携情報
    Summary Analytik Jena AG (Analytik Jena), a subsidiary of Endress+Hauser AG is a provider of instruments and products for analytical measuring technology and life science. The company’s major products include atomic spectrometers, optical emission spectroscopy devices, mass spectrometers, mercury an …
  • Palfinger AG (PAL):企業の財務・戦略的SWOT分析
    Palfinger AG (PAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • UCL Business PLC:企業のM&A・事業提携・投資動向
    UCL Business PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCL Business PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Westwater Resources, Inc.:企業の戦略・SWOT・財務情報
    Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Westwater Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • HNB Assurance PLC (HASU.N0000):企業の財務・戦略的SWOT分析
    HNB Assurance PLC (HASU.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • SynergEyes Inc-医療機器分野:企業M&A・提携分析
    Summary SynergEyes Inc (SynergEyes) is a medical device company that offers contact lenses. The company offers hybrid contact lenses to transform vision for patients with astigmatism, presbyopia, presbyopia, myopia, hyperopia, keratoconus, and other eye conditions. It provides ultrahealth hybrid len …
  • Nick Scali Ltd (NCK):企業の財務・戦略的SWOT分析
    Nick Scali Ltd (NCK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nihon Kohden Corporation:企業の戦略・SWOT・財務分析
    Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report Summary Nihon Kohden Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • China Resources Gas Group Ltd (1193):企業の財務・戦略的SWOT分析
    China Resources Gas Group Ltd (1193) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆